NCT02539576 Pharmacokinetics, Safety and Tolerability Study of Abacavir/ Dolutegravir/ Lamivudine Fixed-dose Combination Tablets in Healthy Japanese Subjects Status COMPLETED Phase PHASE1
NCT02531633 Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis Status TERMINATED Phase PHASE3
NCT02528357 GSK3174998 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (ENGAGE-1) Status COMPLETED Phase PHASE1
NCT02523287 Placebo Controlled Study to Generate Data Characterising Clinical Events, Physiological Responses and Immune Responses Status COMPLETED Phase PHASE4
NCT02523014 Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas Status RECRUITING Phase PHASE2
NCT02522754 Development of an Intranasal Proteosome Influenza Vaccine Status COMPLETED Phase PHASE1/PHASE2
NCT02522299 A Study to Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557 in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Acute Exacerbation Status COMPLETED Phase PHASE2
NCT02519751 New Method Using Deuterium Labelled Creatine to Measure Total Body Skeletal Muscle Mass Status COMPLETED Phase NA
NCT02513654 Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects Status COMPLETED Phase PHASE1
NCT02509104 Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT02508064 Bioavailability of BMS-626529 in Healthy Subjects From Prototype Low Dose Extended Release Formulations (Part 1) and Prototype Extended Release Multi-particulate Formulations (Part 2) of BMS-663068 Relative to 600 mg Extended Release Tablet Status COMPLETED Phase PHASE1
NCT02504671 Study to Evaluate the Efficacy and Safety of GSK3196165 Plus Methotrexate in Subjects With Active Moderate-Severe Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT02502812 Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02502734 Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Status COMPLETED Phase PHASE3
NCT02498288 A Study to Determine Bioequivalence of Isotretinoin in Healthy Male Subjects Under Fed Condition Status COMPLETED Phase PHASE1
NCT02497937 A Study to Evaluate the Effect of the Transient Receptor Potential Vanilloid 4 (TRPV4) Channel Blocker, GSK2798745, on Pulmonary Gas Transfer and Respiration in Patients With Congestive Heart Failure Status COMPLETED Phase PHASE2
NCT02496221 A Study Evaluating the Effect of Albiglutide on Gallbladder Emptying in Healthy Subjects Status COMPLETED Phase PHASE4